Department of Urology, Yale School of Medicine, New Haven, CT, USA.
Quinnipiac University, Hamden, CT, USA.
Urol Clin North Am. 2023 Nov;50(4):563-576. doi: 10.1016/j.ucl.2023.06.014. Epub 2023 Aug 12.
Few transgender-specific cancer screening recommendations exist. This review aims to cover current guidelines and practice patterns of cancer screening in transgender patients and, where evidence-based data are lacking, to draw from cisgender screening guidelines to suggest best practices for transgender patients based on anatomic inventory. Sufficient evidence does not exist to determine the long-term effects of gender-affirming hormone therapy on cancer risk. In the future, cancer screening and prevention should be focused on anatomic inventory and high-risk behaviors.
目前针对跨性别者的癌症筛查推荐意见较少。本综述旨在介绍跨性别者癌症筛查的现行指南和实践模式,在缺乏循证数据的情况下,我们参考顺性别者的筛查指南,根据解剖学特征,为跨性别者提出最佳的筛查建议。目前尚无充分证据确定性别肯定性激素治疗对癌症风险的长期影响。未来,癌症筛查和预防应重点关注解剖学特征和高危行为。